期刊文献+

超选择性子宫动脉化疗栓塞在宫颈癌治疗中的临床价值 被引量:5

Clinical value of super-selective uterine artery embolization in the chemotherapy for cervical cancer
原文传递
导出
摘要 目的:探讨超选择性子宫动脉化疗栓塞在宫颈癌治疗中的疗效及应用价值。方法:选择宫颈癌Ⅰb~Ⅱb期患者56例在超选择性子宫动脉化疗栓塞后行腹腔镜下广泛子宫切除及盆腔淋巴结清扫术作为动脉化疗组,同期Ⅰb~Ⅱa期未行介入化疗直接手术的42例作为对照组,对两组的临床资料进行回顾性分析。结果:动脉化疗组化疗后肿瘤直径较化疗前明显缩小,总有效率89.3%;动脉化疗组手术时间、术中失血量、淋巴结转移及宫旁浸润率均低于对照组,差异有统计学意义(P<0.05);术后膀胱功能、胃肠功能恢复时间及术后并发症发生差异无统计学意义(P>0.05)。结论:术前介入动脉化疗栓塞能明显缩小肿瘤直径,提高手术切除率,减少术中出血,缩短手术时间,不影响术后恢复,不增加术后并发症,是宫颈癌治疗的有效辅助治疗手段。 Objective: To explore the therapeutic efficacy and application value of super - selective uterine artery embolization in the treatment of cervical cancer. Methods: 56 patients with Ⅰ b - Ⅱb period of cervical cancers treated with super selective uterine arte- rial chemotherapy embolism before laparosc0pic hysterectomy and extensive pelvic lymph node dissections were selected into arterial chemo- therapy group, 42 cases with Ⅰ b - Ⅱ a period without intervention chemotherapy while with direct operation were into con'ttol grotip. Clin- ical data were retrospectively analyzed. Results: Tumor diameter was reduced after chemotherapy in arterial chemotherapy group significant- ly, the total effective rate was 89.3%. Operation time, intraoperative blood loss, lymph node metastasis and palace side infiltration rate in ar- terial chemotherapy group were lower than those of control group, the differences were statistically significant ( P 〈 0. 05 ) . There were no statistical differences in postoperative bladder function, gastrointestinal functional recovery time and postoperative complications between arte- rial chemotherapy and control groups (P 〉 0. 05 ) . Conclusion : Preoperative intervention arterial chemotherapy embolism could obviously reduce tumor diameter, improve the surgical excision rate, reduce the intraoperative bleeding, shorten the operation time, but not affect postoperative recovery and not increase the postoperative complications, which is effective auxiliary therapy for cervical cancer.
作者 徐红丽
出处 《中国妇幼保健》 CAS 北大核心 2013年第13期2047-2049,共3页 Maternal and Child Health Care of China
关键词 宫颈癌 动脉化疗栓塞 腹腔镜 Cervical cancer Arterial chemoembolization Laparoscope
  • 相关文献

参考文献7

二级参考文献8

  • 1宋水勤,张国楠.宫颈癌新辅助化疗现状[J].实用医院临床杂志,2005,2(2):22-25. 被引量:53
  • 2陈春林,谭道彩,梁立治.动、静脉灌注化疗子宫颈癌组织药物浓度的比较[J].中华妇产科杂志,1995,30(5):298-298. 被引量:172
  • 3Strecker EP,Heber R,Boos I,et al.Preliminary experience with locoregional intraarterial chemotherapy of uterine cervical or endometrial cancer using the peripheral implantable port system (PIPS):a feasibility study[J].Cardiovasc Intervent Radiol,2003,26(2):118-120.
  • 4Kobayashi K,Furukawa A,Takahashi M,et al.Neoadjuvant intra-arterial chemotherapy for locally advanced uterine cervical cancer:clinical efficacy and factors influencing response[J].Cardiovasc Intervent Radiol,2003,26(3):234-241.
  • 5Micheleti E, Laface B, BianchiE, et al. Continuous infusion of carboplatin during conventional radiothrapy treatment in advanced squamous carcinoma of the eervic uteri ⅡB-ⅢB(UICC) Aphase Ⅰ-Ⅱ and pharmaco kinetic study [J]. Am J Clin Oncol, 1997,20(8) :613 - 620.
  • 6Sugiyama, Nishida T, Hasuo Y, et al. Neoadjuvant Interarterial Clemraotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cancer [J]. Cynecol Oncvol, 1998,69(2) : 130.
  • 7陈春林,梁立治,刘佩鸣,谭道彩,马奔,方艺川,余莉萍,何燕.介入治疗在中晚期妇科恶性肿瘤中应用的临床研究[J].中国实用妇科与产科杂志,2000,16(11):667-669. 被引量:113
  • 8于月成,汪海丹,辛晓燕,李贵容,赵海波,王滨.术前介入化疗治疗巨块型宫颈癌52例疗效分析[J].第四军医大学学报,2004,25(6):557-559. 被引量:47

共引文献272

同被引文献49

  • 1田种泽,刘茗露,王光辉,李莎,尹华,岳养军,朱向辉.根治性放疗前子宫动脉化疗栓塞与子宫动脉灌注化疗在中晚期宫颈癌治疗中的应用价值[J].中华临床医师杂志(电子版),2012,6(21):6749-6753. 被引量:10
  • 2贺斌,谭隆旺,孙寒,成友华,俞赶年.介入化疗栓塞在宫颈癌手术治疗中的应用[J].昆明医学院学报,2012,33(3):96-99. 被引量:15
  • 3钱朝霞,李群英,徐文英.子宫动脉栓塞在宫颈或切口妊娠人工流产手术前的作用[J].中国医学计算机成像杂志,2006,12(3):200-202. 被引量:43
  • 4Cheng PJ,Chueh HY,Soong YK.Sonographic diagnosis of a uterine defect in a pregnancy at 6 weeks gestation with a history of curettage[J].Uhrasound Obstet Gynecol,2003,21 (5) :501-503.
  • 5Oechsle K, Goerth K, Bokemeyer C, et al. Symptom bur- den in palliative care patients: perspectives of patients, their family caregivers, and their attending physicians[ J ]. Support Care Cancer, 2013,21 (7) : 1955-1962.
  • 6Keall R M, Butow P N, Steinhauser K E, et al. Nurse- facilitated preparation and life completion interventions are acceptable and feasible in the Australian palliative care setting: results from a phase 2 trial [ J]. Cancer Nurs, 2013,36(3) .E39-E46.
  • 7Van Cleave J H, Egleston B L, Ercolano E, et al. Symp- tom distress in older adults following cancer surgery [ J ]. Cancer Nuts, 2013,36(4) :292-300.
  • 8Abu-Saad Huijer H, Abboud S, Doumit M. Symptom prevalence and management of cancer patients in Lebanon [ J]. J Pain Symptom Manage, 2012,44(3 ) :386-399.
  • 9Browall M, Kenne Sarenmalm E, Nasic S, et al. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS) : an instrument for the evaluation of symptom prevalence, characteristics, and distress[ J]. J Pain Symptom Manage, 2013,46( 1 ) : 131-141.
  • 10Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61:69-90.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部